Patents by Inventor Ri Ra LEE

Ri Ra LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230322856
    Abstract: The present invention relates to Regentide-012 and Regentide-013 and, more specifically, to a use of Regentide-012 and Regentide-013 for improving skin conditions. Regentide-012 and Regentide-013 according to the present invention is free of cytotoxicity and have remarkable effects of skin aging reduction, skin regeneration, skin elasticity improvement, skin wrinkle prevention, skin wrinkle reduction, and skin wound recovery and as such, can be variously utilized in the pharmaceutical, medicinal, cosmetic, and food fields.
    Type: Application
    Filed: June 8, 2021
    Publication date: October 12, 2023
    Inventors: Jae Hwan KIM, Ji Heon RHIM, Ri Ra LEE, Hye In AHN, Hae Yeong KANG, Ga Hyun KIM
  • Publication number: 20230220006
    Abstract: The present invention relates to regentide-034 and, more specifically, to a use of regentide-034 for improving the condition of the skin. Regentide-034 according to the present invention is noncytotoxic and has remarkable effects of skin aging alleviation, skin regeneration, skin elasticity improvement, skin wrinkle prevention, skin wrinkle reduction and skin wound regeneration, and thus can be variously used in the fields of pharmacology, medicine, cosmetics, and food.
    Type: Application
    Filed: June 8, 2021
    Publication date: July 13, 2023
    Inventors: Jae Hwan KIM, Ji Heon RHIM, Ri Ra LEE, Hye In AHN, Hae Yeong KANG
  • Publication number: 20230210748
    Abstract: The present invention relates to Regentide-034 and Regentide-041 and, more specifically, to a use of a mixture of Regentide-034 and Regentide-041 for improving skin conditions. A mixture of Regentide-034 and Regentide-041 according to the present invention is free of cytotoxicity and has remarkable effects of promoting cell proliferation and collagen synthesis, inhibiting elastase activity, and suppressing ultraviolet light-induced cell death and as such, can be variously utilized in the pharmaceutical, medicinal, cosmetic, and food fields.
    Type: Application
    Filed: June 8, 2021
    Publication date: July 6, 2023
    Inventors: Jae Hwan KIM, Ji Heon RHIM, Ri Ra LEE, Hye In AHN
  • Publication number: 20230159590
    Abstract: The present invention relates to Regentide-041 and, more specifically, to a use of Regentide-041 for improving skin conditions. Regentide-041 according to the present invention is free of cytotoxicity and has remarkable effects of skin aging reduction, skin regeneration, skin elasticity improvement, skin wrinkle prevention, skin wrinkle reduction, and skin wound recovery and as such, can be variously utilized in the pharmaceutical, medicinal, cosmetic, and food fields.
    Type: Application
    Filed: June 8, 2021
    Publication date: May 25, 2023
    Inventors: Jae Hwan KIM, Ji Heon RHIM, Hye In AHN, Ri Ra LEE, Hae Yeong KANG